The current earnings forecast score of InfuSystem Holdings Inc is 8.50, ranking 30 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 15.00, with a high of 15.00 and a low of 12.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
14.875
Target Price
+52.41%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
InfuSystem Holdings Inc
INFU
4
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is InfuSystem Holdings Inc's expected revenue for the next quarter?
InfuSystem Holdings Inc's expected revenue is 36.35M.
What is InfuSystem Holdings Inc's price target?
Analysts forecast that InfuSystem Holdings Inc's price target is USD 15.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 12.00.
How have InfuSystem Holdings IncINFU's recent earnings per share performed?
The market expectation was USD 0.05, while InfuSystem Holdings IncINFU's earnings per share (EPS) for the previous quarter was USD 0.10. EPS for the next quarter is expected at USD 0.10.
What is the analyst rating for InfuSystem Holdings Inc?
Based on the ratings of InfuSystem Holdings Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.